Accueil › Leucémie › Illinois › Chicago
Essais cliniques pour Leucémie à Chicago, IL
16 études pour Leucémie recherchent des participants dans et autour de Chicago (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Recrutement en coursPhase 1/2
- The University of Chicago Medical Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Recrutement en coursPhase 3
- Research Site, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Recrutement en coursPhase 1/2
- University of Chicago, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recrutement en coursPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Recrutement en coursPhase 1/2
- Research Site, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Recrutement en coursPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Recrutement en cours
- Northwestern University Feinberg School of Medicine, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
Recrutement en coursPhase 2
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Recrutement en coursÉtude observationnelle
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Recrutement en coursPhase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Recrutement en coursPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
Recrutement en cours
- UChicago Medicine Comprehensive Cancer Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Recrutement en coursPhase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Recrutement en cours
- University of Chicago Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Recrutement en coursPhase 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Essais pour Leucémie dans d'autres villes
- Houston, TX28 études
- Boston, MA25 études
- New York City, NY19 études
- Los Angeles, CA16 études
- Durham, NC13 études
- Nashville, TN12 études
- Baldwin Park, CA12 études
- Columbus, OH12 études
- Philadelphia, PA12 études
- Seattle, WA11 études
- Milwaukee, WI11 études
- Birmingham, AL10 études
Autres études à Chicago
- Cancer du poumon non à petites cellules61 études
- Cancer du sein58 études
- Cancer (tous types)52 études
- Cancer métastatique45 études
- Cancer de la prostate45 études
- Obésité42 études
- Cancer du poumon41 études
- Cancer de l'ovaire36 études
- Accident vasculaire cérébral34 études
- Insuffisance cardiaque32 études
- Cancer colorectal32 études
- Surpoids28 études
Source : ClinicalTrials.gov, données récupérées le 1 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.